Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Elisabeth Hertle"'
Autor:
Carla J.H. van der Kallen, Marleen M.J. van Greevenbroek, Casper G. Schalkwijk, Elisabeth Hertle, Ying Xin, Coen D.A. Stehouwer
Publikováno v:
Diabetologia, 63(5), 1032-1042. Springer, Cham
Diabetologia
Diabetologia
Aims/hypothesis Reactive α-dicarbonyl compounds are major precursors of AGEs and may lead to glycation of circulating and/or cell-associated complement regulators. Glycation of complement regulatory proteins can influence their capacity to inhibit c
Autor:
Carla J.H. van der Kallen, Nicole Vogelzangs, Ying Xin, Coen D.A. Stehouwer, Elisabeth Hertle, Marleen M.J. van Greevenbroek, Casper G. Schalkwijk, Ilja C. W. Arts
Publikováno v:
Journal of Clinical Lipidology, 15(2), 311-319. Elsevier BV
BACKGROUND: Plasma lipoproteins contain heterogeneous subclasses. Previous studies on the associations of the complement system with lipids and lipoproteins are mainly limited to the major lipid classes, and associations of complement with lipoprotei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::826ee0c48571321434f55072b7741b25
https://cris.maastrichtuniversity.nl/en/publications/c7dbe3d3-16dc-4072-b75f-b9fe26a1412b
https://cris.maastrichtuniversity.nl/en/publications/c7dbe3d3-16dc-4072-b75f-b9fe26a1412b
Autor:
Ying Xin, Elisabeth Hertle, Carla J.H. van der Kallen, Marleen M.J. van Greevenbroek, Casper G. Schalkwijk, Coen D.A. Stehouwer
Publikováno v:
Obesity Research & Clinical Practice, 12(3), 286-292. Elsevier BV
Objective: To investigate longitudinal associations of components of the alternative (C3, C3a, Bb, factor D [FD], factor H [FH], and properdin) and the terminal complement pathway (C5a, sC5b-9) with adiposity. Methods: A prospective human cohort stud
Autor:
Carla J.H. van der Kallen, Elisabeth Hertle, Ilja C. W. Arts, Marleen M.J. van Greevenbroek, Coen D.A. Stehouwer, Casper G. Schalkwijk, Edith J. M. Feskens
Publikováno v:
Arteriosclerosis Thrombosis and Vascular Biology, 38, 1242-1244
Arteriosclerosis Thrombosis and Vascular Biology, 38(5), 1242-1244. LIPPINCOTT WILLIAMS & WILKINS
Arteriosclerosis Thrombosis and Vascular Biology 38 (2018)
Arteriosclerosis Thrombosis and Vascular Biology, 38(5), 1242-1244. LIPPINCOTT WILLIAMS & WILKINS
Arteriosclerosis Thrombosis and Vascular Biology 38 (2018)
Objective— The classical complement pathway has been assigned both protective and pathological effects in cardiovascular disease (CVD), but human data are lacking. We determined the associations of the pattern recognition factor C1q and the regulat
Autor:
Elisabeth Hertle, Carla J.H. van der Kallen, Ilja C. W. Arts, Ingeborg Torp Hoffmann-Petersen, Edith J. M. Feskens, Casper G. Schalkwijk, Coen D.A. Stehouwer, Marleen M.J. van Greevenbroek, Steffen Thiel
Publikováno v:
Hertle, E, Arts, I C W, van der Kallen, C J H, Feskens, E J M, Schalkwijk, C G, Hoffmann-Petersen, I T, Thiel, S, Stehouwer, C D A & van Greevenbroek, M M J 2016, ' Distinct Longitudinal Associations of MBL, MASP-1, MASP-2, MASP-3, and MAp44 With Endothelial Dysfunction and Intima-Media Thickness : The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study ', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, no. 6, pp. 1278-85 . https://doi.org/10.1161/ATVBAHA.115.306552
Arteriosclerosis Thrombosis and Vascular Biology, 36(6), 1278-1285. LIPPINCOTT WILLIAMS & WILKINS
Arteriosclerosis Thrombosis and Vascular Biology, 36(6), 1278-1285. LIPPINCOTT WILLIAMS & WILKINS
Objective— Previous studies suggested that the lectin-complement pathway plays a complex role in cardiovascular disease (CVD). To date, no prospective human studies have investigated the relationship between the initiating factor of the lectin path
The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes
Autor:
Marleen M.J. van Greevenbroek, Ilja C. W. Arts, Elisabeth Hertle, Casper G. Schalkwijk, Edith J. M. Feskens, Coen D.A. Stehouwer, Carla J.H. van der Kallen
Publikováno v:
Thrombosis and Haemostasis 115 (2016) 2
Thrombosis and Haemostasis, 115(2), 446-457. Georg Thieme Verlag
Thrombosis and Haemostasis, 115(2), 446-457
Thrombosis and Haemostasis, 115(2), 446-457. Georg Thieme Verlag
Thrombosis and Haemostasis, 115(2), 446-457
SummaryThe alternative pathway of complement activation is highly reactive and can be activated spontaneously in the vasculature. Activation may contribute to vascular damage and development of cardiovascular disease (CVD). We aimed to investigate fu
Autor:
Elisabeth Hertle, Marleen M.J. van Greevenbroek, Ying Xin, Casper G. Schalkwijk, Coen D.A. Stehouwer, Carla J.H. van der Kallen
Publikováno v:
Endocrine
Endocrine, 62(3), 617-627. Springer
Endocrine, 62(3), 617-627. Springer
Purpose We investigated the associations of components of the alternative (C3, C3a, Bb, factor D [FD], factor H [FH], properdin) and the classical complement pathway (C4, C1q, C1-inhibitor [C1-INH]) with prevalent and incident metabolic syndrome in a
Autor:
Stefan L.C. Geijselaers, Eugène H.J.M. Jansen, M.M.J. van Greevenbroek, Casper G. Schalkwijk, C.J.H. van der Kallen, Elisabeth Hertle, Ilja C. W. Arts, Edith J. M. Feskens, Coen D.A. Stehouwer
Publikováno v:
Thrombosis and Haemostasis, 111(6), 1102-1111. Georg Thieme Verlag
SummaryComplement C3 is a novel risk factor for cardiovascular disease (CVD), but the underlying mechanism is currently unknown. We determined the associations of the anaphylatoxin C3a, the activation product of C3, and of C3 itself with estimates of
Autor:
Ying Xin, Marleen M.J. van Greevenbroek, Elisabeth Hertle, Casper G. Schalkwijk, Coen D.A. Stehouwer, Carla J.H. van der Kallen
Publikováno v:
Molecular Immunology. 89:190
Autor:
Marleen M.J. van Greevenbroek, Ying Xin, Elisabeth Hertle, Carla J.H. van der Kallen, Casper G. Schalkwijk, Thomas Schuitemaker, Coen D.A. Stehouwer
Publikováno v:
Molecular Immunology. 89:189